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PSurgery for Congenital Heart Disease
Causes of Late Deaths After Pediatric Cardiac Surgery
A Population-Based Study
Heta P. Nieminen, MD,* Eero V. Jokinen, MD,† Heikki I. Sairanen, MD*
Helsinki, Finland
Objectives We examined the causes and modes of late death after pediatric cardiac surgery.
Background The late mortality of patients operated on for congenital heart defect (CHD) is comprehensively unexamined.
In this study, the causes of death were examined to obtain further knowledge of the morbidity of the patients.
Methods We studied all late deaths of patients operated on for CHD in Finland during the years 1953 to 1989. We calcu-
lated the survival of patients, identified the causes of deaths from death certificates, and examined the modes
of CHD-related deaths. We compared the survival and the causes of non–CHD-related deaths to those of the gen-
eral population.
Results Of the 6,024 patients who survived their first operation, 592 (9%) died during the 45-year follow-up period.
The progress of treatment was seen in the survival of the patients operated on in different decades. The cause
of death was confirmed with postmortem examination in 474 (81%) cases. The majority of patients (397, 67%)
died owing to the CHD. Furthermore, non–CHD-related mortality was twice as high (risk ratio 1.9, 95% confi-
dence interval 1.5 to 2.4) as expected. The main mode for CHD-related death was heart failure (40%). Other
modes included perioperative (26%), sudden (22%), and cardiovascular (12%) deaths. The number of deaths
caused by neurological and respiratory diseases was higher and the number of accidental deaths was lower
than expected.
Conclusions The survival of patients was lower than that of the general population (relative 45-year survival 89%). Most pa-
tients died owing to CHDs, but non–CHD-related mortality was also high. (J Am Coll Cardiol 2007;50:1263–71)
© 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.05.040W
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chis present study is the first population-based evaluation
f the causes of late death after pediatric cardiac surgery.
he comprehensive coverage and reliability of the Finnish
opulation register and the Finnish research register of
ediatric cardiac surgery enabled us to complete this unique
tudy. Our study includes all children operated on for
ongenital heart defects (CHDs) in Finland during the
ears 1953 to 1989, and we were able to confirm the late
utcome of 96% of them.
For the first time, the causes of death of CHD patients
ould be compared with those of the general population.
reviously, the causes of late deaths were reported incom-
letely only as part of follow-up investigations (1–5).
The results of pediatric cardiac surgery are good, but
ortality still remains higher than in the general population
6,7). Most of the patients die owing to their cardiac defect.
rom the Departments of *Surgery and †Cardiology, Hospital for Children and
dolescents, Helsinki University Central Hospital, Helsinki, Finland. This work was
upported by the Finnish Slot Machine Association, Finnish Association for Heart
hildren and Adults, Finnish Foundation for Cardiovascular Research, Finnish
oundation for Pediatric Research, and the Finnish Medical Foundation.o
Manuscript received December 12, 2006; revised manuscript received April 27,
007, accepted May 22, 2007.ith active and well-timed interventions, however, the
ifespan of these patients can be prolonged. Therefore, an
nderstanding of the causes and the mechanisms of death
lay an important role in improving late prognosis.
The gender difference in the late mortality of CHD
atients has not yet been studied. Gender could be a factor
n the prognosis of such patients, because significant differ-
nces have been found in the mechanisms of arrhythmias
etween genders (8), and sudden death due to coronary
eart disease is more common among male patients (9).
ethods
ccording to the Finnish Research Registry of Pediatric
ardiac Surgery, a total of 7,240 cardiac operations were
erformed on 6,460 children in Finland during the years
953 to 1989.
The current state of patients on the closing day of this study
October 28, 1998) and the dates of death and emigration were
btained from the Finnish Population Registry Centre. The
auses of late death were identified from death certificates
btained from Statistics Finland. If something unclear ap-
r
i
t
Q
c
(
h
d
c
s
p
3
o
r
g
F
S
w
a
s
(
t
d
w
s
v
F
o
F
o
e
i
c
H
m
g
[
t
b
d
n
t
w
g
o
(
d
i
d
P
s
o
R
O
o
i
i
(
d
s
e
e
i
k
a
6
l
(
t
t
w
5
o
V
m
h
y
d
d
o
r
1264 Nieminen et al. JACC Vol. 50, No. 13, 2007
Deaths After Pediatric Cardiac Surgery September 25, 2007:1263–71peared in the death certificate, we
examined the patient’s medical
records.
The patients were divided into
different heart defect groups ac-
cording to a previously pub-
lished hierarchy based on their
primary diagnosis (6). We in-
vestigated separately the mortality
of patients with patent ductus ar-
teriosus (PDA), coarctation of
aorta (CoA), atrial septal defect
(ASD), ventricular septal defect
(VSD), tetralogy of Fallot (TOF),
transposition of the great arteries
(TGA), and univentricular heart
(UVH) who had survived their
first operation (i.e., were alive30
days after).
The deaths were first divided
by their main cause into CHD-
elated and non–CHD-related deaths; CHD-related causes
ncluded deaths caused by diseases with ICD-10 (Interna-
ional Classification of Diseases) diagnosis numbers Q20 to
28 (in old cases ICD-9 numbers 745 to 747). All other
auses were classified as non–CHD-related.
An existing classification of the cardiac cause of deaths
10) served to divide the CHD-related deaths into 4 groups:
eart failure, sudden, perioperative, and cardiovascular
eath. Sudden death was defined as death due to cardiovas-
ular causes within 1 h of onset (or significant worsening) of
ymptoms or unwitnessed death during sleep (11). The
erioperative deaths included all early postoperative (within
0 days) deaths due to patient’s second, third or fourth
peration. The cardiovascular group included all CHD-
elated deaths that could not be classified into the other 3
roups.
This study was conducted with the permission of the
innish Ministry of Social Affairs and Health.
tatistical methods. Time-related mortality was assessed
ith survival analysis. Survival was calculated for all patients
nd separately for gender and diagnostic groups. The
urvival rate of patients operated on in different decades
1950s to 1980s) was also calculated separately to evaluate
he progress of treatment. We compared the survival rates of
ifferent gender and decade groups and analyzed survival
ith and without non–CHD-related causes of death. The
urvival statistics were calculated with SURV3, the latest
ersion of the survival analysis package developed at the
innish Cancer Registry (12).
We compared each patient’s individual survival with that
f the age-, gender-, and time-matched general population.
or every patient and for every year of follow-up, we
btained the mortality of the general population. The
xpected probability of surviving 1 year was obtained for all
Abbreviations
and Acronyms
ASD  atrial septal defect
CHD  congenital heart
defect
CI  confidence interval
CoA  coarctation of aorta
PDA  patent ductus
arteriosus
PS  pulmonary stenosis
RR  relative risk
SMR  standardized
mortality ratio
TGA  transposition of the
great arteries
TOF  tetralogy of Fallot
UVH  univentricular heart
VSD  ventricular septal
defectndividuals who, regardless of their survival status, were not yensored before the beginning of the interval. We used the
akulinen method (13) for combining the individual infor-
ation with an estimate for the expected survival of the
roup.
The relative risk (RR) (with 95% confidence intervals
CIs]) analysis was used in evaluating the differences be-
ween observed versus expected numbers of deaths and
etween genders. If the CI of RR did not include 1.0, the
ifference was considered significant. Furthermore, the
arrower the range of interval, the more significant was
he difference.
The non–CHD-related causes of death of the patients
ere compared with the cause-specific mortality of the
eneral population. The results appear as numbers of deaths
bserved and expected and as standardized mortality ratios
SMRs). The SMR expresses the ratio of observed causes of
eath to that expected on the basis of overall mortality rates
n the general Finnish population. The expected numbers of
eaths were standardized for age, gender, and time. The
oisson distribution was used to calculate the 95% CI. The
ignificance of SMR was calculated with the approximation
f Byar for the exact Poisson test (14).
esults
n the closing day of the study, the condition of all 6,460
perated patients was confirmed from the population reg-
stry: 5,193 (80%) patients were known to be alive and living
n Finland. Altogether, 1,028 (16%) patients had died; 436
7%) died early (30 days), and 592 (9%) died late (30
ays) after the first operation. The outcome of 239 (4%)
urviving patients remained unknown, because they were
ither unidentifiable from the population registry or had
migrated. However, 134 emigrated patients were included
n the survival analysis, because their emigration date was
nown and served as the censoring date. Thus, the survival
nalysis included altogether 5,919 patients (98% of the
,024 patients), all who were alive, had emigrated, or died
ate after surgery.
Of these 5,919 patients, 2,732 were male and 3,187
54%) female. The CHDs were distributed unequally be-
ween genders. The vast majority (71%, 1,377 of 1,932) of
he PDA patients and 60% (461 of 767) of ASD patients
ere female. Male patients more often exhibited CoA (66%,
83 of 880), TOF (60%, 246 of 413), and TGA (66%, 172
f 259). The proportion of male and female patients with
SD and UVH were equal.
A total of 592 patients died late after surgery. The
ortality was highest shortly after the first operation. One
undred sixty-four (28%) deaths occurred during the first
ear, and almost one-half of them (n  79, 48%) occurred
uring the first 3 months after surgery. The patients that
ied were significantly younger at the time of their first
peration than the patients that survived, 3.9 (median 1.3,
ange 0 to 15) years versus 5.4 (median 5.1, range 0 to 15)
ears (p  0.001), respectively. The mean age of late death
w
d
a
b
c
(
u
g
p
n
g
o
g
r
w
b
h
f
t
i
t
s
C
d
w
i
1
i
d
s
d
t
(
1
P
n
1265JACC Vol. 50, No. 13, 2007 Nieminen et al.
September 25, 2007:1263–71 Deaths After Pediatric Cardiac Surgeryas 13.3 (median 10.2, range 0.1 to 53) years. The patients
ied, on average, 9.4 (median 5.8, range 0.08 to 39) years
fter their first operation.
The cause of death was identified in 582 patients and had
een confirmed with postmortem examination in 474 (81%)
ases. A total of 397 (67%) deaths were related and 185
31%) were unrelated to CHDs. The cause of death was
ndetermined in 10 (2%) patients. In most diagnostic
roups, CHD-related causes of death dominated. Only
atients with PDA and ASD died more often owing to
on–CHD-related causes (Fig. 1).
The survival of the patients was lower than that of the
eneral population (Fig. 2). The relative survival for 45 years
f patients was 89% (in relative survival, the survival of the
eneral population is always 100%). When only CHD-
elated deaths were included in the analysis, 45-year survival
as 96%. Most patients died owing to their heart defects,
ut the number of non–CHD-related deaths was also
igher than expected: 185 versus 97, respectively. The RR
or non–CHD-related death was 1.9 (95% CI 1.5 to 2.4).
The overall relative survival of male patients was lower
han that of female patients (p  0.042) (Fig. 2).
When only CHD-related causes of death were included
n the analysis the difference in survival disappeared. Within
he diagnostic groups, we found no significant differences in
urvival between genders either in overall mortality or
HD-related mortality.
The survival rates of all patients operated on decreased
ecade after decade. This reflects the fact that more children
ith severe CHDs were treated during the last decades than
n the earlier decades of our study period. During the 1960s,
Figure 1 Proportion of Causes of Death
Numbers in blocks define the actual number of deaths in each diagnostic group. A
PDA  patent ductus arteriosus; TGA  transposition of the great arteries; TOF ,347 patients were operated on, and most of them exhib-ted simpler defects than did the 2,418 patients operated on
uring the 1980s (Fig. 3).
The survival of those patients with PDA who underwent
urgery in the 1980s was significantly poorer than that
uring earlier decades (p  0.001). This result was due to
he difference in the number of neonates operated on: 29%
186 of 631) in the 1980s, and only 4% (22 of 525) in the
970s. The difference in survival rates between decades in
DA patients and also in all patients disappeared when
on–CHD-related causes were excluded, indicating that
atrial septal defect; CoA  coarctation of aorta;
ogy of Fallot; UVH  univentricular heart; VSD  ventricular septal defect.
Figure 2 Relative Survival (Survival of Patients/
Survival of General Population) of All Patients
Survival of general population is 100%. Dotted lines represent survival for con-
genital heart defect (CHD)-related causes. Follow-up started from the patient’s
first operation.SD 
tetral
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Deaths After Pediatric Cardiac Surgery September 25, 2007:1263–71ost of the neonates were small, premature babies dying
rom non-cardiac causes (Fig. 3).
As expected the relative survivals of patients with CoA,
SD, VSD, and TGA improved over the years (Fig. 3).
The survival of the patients with TOF who underwent
urgery in the 1980s was worse than of those in the 1970s.
he increase in mortality resulted mainly because patients were
ounger at the time of their operation, mean 2.8 versus 6.3
ears (p  0.001), respectively. Also within the patients
perated on during the 1980s the difference in age was
ignificant. The mean age at operation for survivors was 3.0
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Figure 3 Survival of Patients After Their First Operation
Division is by the decade during which the patient underwent the first surgery. The
the 1980s, when only CHD-related deaths were included in the analysis. Follow-up
ages marked as “cor” represent the proportion of patients whose first operation h
†Patient died 15 years after closure of PDA; VSD was not surgically corrected. **nd 1.1 for those who died late after surgery, p  0.015. dThe survival of the patients with univentricular heart was
oor. The 19-year survival for those operated on in the
970s was better than for those operated on in the 1980s,
8% versus 55%, respectively. The higher mortality in the
980s was explained by the fact that more and more
omplicated defects came within the reach of surgery. For
nstance, during the 1980s, of the 56 operated UVH
atients 8 (14%) had a combination UVH, TGA, and CoA,
hereas in the 1970s only 1 (3%) of the 33 operated UVH
atients had this complex defect.
The survival curves of different diagnostic groups and
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September 25, 2007:1263–71 Deaths After Pediatric Cardiac Surgeryode of CHD-related deaths. Most CHD-related deaths
esulted from heart failure (158 of 397, 40%) (Table 1),
hich was the main mechanism of death in PDA, TGA,
nd UVH groups (Fig. 4). One-fourth (38 of 158) of the
atients who died owing to heart failure had been previously
iagnosed with pulmonary hypertension.
A total of 104 (26%) late CHD-related deaths resulted
rom a second, third, or fourth heart operation. The
ajority of perioperative deaths (54, 52%) occurred early
within 30 days) after the corrective operation among
atients whose first operation had been palliative; 31 pa-
ients died early after re-operation, and 19 died after
alliative surgery.
Surgery was the main mode of death among patients with
OF (20 of 60 deaths); 11 died early after the corrective
peration, 7 after re-operation, and 2 after palliative
peration.
Of the CHD-related deaths, 88 (22%) occurred suddenly.
he mean age at sudden death was 19.3 years, whereas it
anged from 8.2 to 12.8 years in the other groups (Table 1).
he vast majority of these patients had undergone corrective
urgery (60 of 88, 68%). In most cases, sudden death
esulted from arrhythmia, because no other reason for death
Figure 4 Proportion of Modes of CHD-Related Death in Differen
Perioperative  death within 30 days after second, third, or fourth operation. Num
in blocks define the actual number of deaths in each group. Abbreviations as in F
Mode of Cardiac Death
Table 1 Mode of Cardiac Death
Deaths
Median
1st Op (yrs
Heart failure 158 40% 0.7 (0–
Perioperative* 104 26% 0.4 (0–
Sudden death 88 22% 5.0 (0–
Cardiovascular 46 12% 2.3 (0–
Unknown 1 0% 12
All 397 100% 0.9 (0–*Death within 30 days after second, third, and fourth operation (Op).ould be found in postmortem examination (84%, 74 of 88
ere examined). The majority of these patients had arrhyth-
ias in their medical history. The other underlying causes
f sudden death appear in Table 2.
Sudden death was the most common mode of death
mong patients with CoA (13 of 31, 42%) (Fig. 4). Of the
3 CoA patients who died suddenly, 5 (38%) exhibited
ntreated valvular aortic stenosis (AS). In 4 cases, the
nderlying cause was a ruptured or dissected aorta.
Among patients with TOF (18 of 60) and TGA (19
f 63), 30% of CHD-related deaths were sudden; 6% (15
f 246) of male patients with TOF and 10% (17 of 171) of
ale patients with TGA died suddenly. The proportion of
udden deaths among female patients was 2% in both
roups (3 of 168, 2 of 171, respectively). The RR of sudden
eath for male patients was 3.4 (95% CI 1.004 to 11.6) in
he TOF group and 4.3 (95% CI 1.02 to 18.3) in the TGA
roup. When these 2 diagnostic groups were combined, the
R of sudden death for male patients was 3.9 (95% CI 1.5
o 9.9).
The only death caused by anti-coagulation therapy was
lso sudden: 1 patient with an operated CoA and a
rosthetic aortic valve died owing to subarcachnoidal bleed-
ect Groups
1 and 2.
t
ge)
Median Follow-Up
Time (yrs) (range)
Median Age at
Death (yrs) (range)
2.1 (0.1–38.9) 5.2 (0.1–52.1)
2.7 (0.1–30.9) 3.9 (0.1–41.3)
12.7 (0.2–37.0) 18.4 (0.2–47.6)
2.0 (0.1–34.2) 7.6 (0.1–45.3)
1.1 13.2
4.3 (0.1–38.9) 7.7 (0.1–52.1)t Def
bers
igures Age a
) (ran
14.9)
14.4)
14.3)
14.9)
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Deaths After Pediatric Cardiac Surgery September 25, 2007:1263–71ng. The patient’s treatment with warfarin was complicated
y alcohol abuse.
Cardiovascular diseases related to congenital defects
Table 2) caused 46 (12%) deaths. In this subgroup, 3
iseases dominated: stroke (11 deaths), arrhythmia (6), and
ulmonary emboli (6). Endocarditis caused 4 deaths, ac-
ounting for 1% of all CHD-related deaths. The overall
ncidence of lethal endocarditis was 0.07% (4 of 6,024).
wo of these 4 patients had a bicuspic aortic valve, 1
xhibited re-coarctation, and 1 patient with UVH failed to
ecover from the Fontan operation. Brain abscess caused 4
eaths, 2 of which occurred among patients with pulmonary
ypertension, and the other 2 patients had non-corrected
yanotic heart defects (TGA and TOF). Three patients died
wing to myocardial infarct: 1 suffered from severe familial
ypercholesterolemia (AS), 1 had anomalous coronary ar-
eries (VSDCoA), and 1 patient (CoA, AS, and Turner’s
yndrome) had an occluded coronary artery. In 2 cases, the
yocardial infarction was classified as non–CHD-related:
he first involved a 44-year-old patient with operated CoA,
evere diabetes with several complications, and a kidney
ransplant; and the second was a 36-year-old patient with
perated PDA. Pulmonary hemorrhage was the cause of
eath of 2 patients, both of whom had Eisenmenger’s
yndrome. In addition, 1 patient with Eisenmenger’s syn-
rome died suddenly due to massive acute pulmonary
auses of Sudden and Cardiovascular Deaths
Table 2 Causes of Sudden and Cardiovascular Deaths
n
Cause of sudden death
Arrhythmia/heart failure/unknown 73
Rupture of aorta 5
Pulmonary emboli 3
Myocardial infarct 2
Shunt occlusion 2
Rupture of an aneurysm of MPA 1
Subarchacnoidal bleeding 1
Pulmonary hemorrhage 1
All 88
Cardiovascular causes of death
Stroke 11
Arrhythmia 6
Pulmonary emboli 6
Endocarditis 4
Brain abscess 4
Thrombosis 4
Myocardial infarct 3
Rupture of an aneurysm of PDA 2
Valve prothesis complication
(aortic)
2
Pulmonary hemorrhage 2
Pericarditis 1
Myocarditis 1
All 46
PA  main pulmonary artery; PDA  patent ductus arteriosus.leeding. aauses of non–CHD-related deaths. The cause of death
n 185 patients was unrelated to cardiac malformation.
iseases caused 127 deaths, and 58 deaths were violent. We
ound no differences between genders in the causes of
on-CHD deaths.
The patients died of respiratory and neurological diseases
ignificantly more often than did the general population
Table 3). Of the 17 respiratory deaths, 11 resulted from
neumonia in mentally retarded patients (6) and infants (5).
he most common neurological causes of death were
pilepsy (6) and meningitis (4).
The patients died in accidents less often than the general
opulation. The number of accidental deaths was 28 in the
atient population; the expected value was 44 (SMR 0.64,
5% CI 0.42 to 0.92).
The number of suicides was similar to the number
xpected. All 23 patients who committed suicide had
ndergone corrective surgery. The patients had undergone
urgery at least 5 (mean 16.8) years before death (9 PDA, 3
oA, 3 pulmonary stenosis [PS], 4 VSD, 3 ASD, 1 TOF).
wo suicides were directly connected to heart defects: 1
SD patient exhibited severe arrhythmias resistant to treat-
ent, and 1 patient with PS took her own life rather than
gree to another operation.
iscussion
n the present population-based study, we examined all late
eaths after pediatric cardiac surgery in Finland. The
ccurate research registry of pediatric cardiac surgery in
inland guarantees the reliability and coverage of the study.
he number of patients lost to follow-up was 239, only 4%
f all 6,024 who survived their first cardiac operation.
Statistics Finland helped us identify the cause of death in
8% of cases. Of the causes, 81% were confirmed with
ostmortem examination, considered a valuable way of
nvestigating the mechanism of death even today (15).
The number of deaths was high throughout the follow-up
ears when compared with general population. The mortal-
ty was highest within the first year of follow-up. The high
ortality during the first years appears in all previously
ublished survival curves (2,5,7). The survival of male
atients was poorer than that of female patients. As far as
e know, this gender difference has not been previously
ublished. The obvious cause was the difference in the
eriousness of the defects.
In most diagnostic groups, the long-term results im-
roved with every decade. However, in some groups the
urvival was worse in patients operated on in the 1980s. The
ower survival rate was caused by more complicated defects
nd younger age at the time of surgery, both of which are
nown risk factors for mortality (16). The early mortality
fter procedures made for neonates has decreased in 1990s
nd 21st century (17). Yet only the future will show whether
he improved early survival of infants in the current era will
lso lead to decreased late mortality.
Observed and Expected Causes of Deaths Unrelated to Congenital Heart Defect
Table 3 Observed and Expected Causes of Deaths Unrelated to Congenital Heart Defect
All Deaths (n  185) Age at Death <20 yrs (n  110) Age at Death >20 yrs (n  75)
Patients Expected SMR 95% Cl p Value Patients Expected SMR 95% Cl p Value Patients Expected SMR 95% Cl p Value
Diseases 127 110.85 1.15 (0.96–1.15) 87 75.93 1.15 (0.92–1.41) 40 34.92 1.15 (0.82–1.56)
Infectious diseases 1 2.84 0.35 (0.01–1.96) 1 2.18 0.46 (0.01–2.56) 0 0.66 0.00 (0.00–5.59)
Neoplasms 18 19.30 0.93 (0.55–1.47) 7 8.67 0.81 (0.32–1.66) 11 10.64 1.03 (0.52–1.85)
Endocrine, nutritional, and
metabolic diseases
5 3.62 1.38 (0.45–3.22) 1 1.96 0.51 (0.01–2.84) 4 1.67 2.40 (0.65–6.13)
Diseases of the nervous
system
14 6.26 2.24 (1.22–3.75) 0.01 9 3.99 2.26 (1.03–4.28) 0.04 5 2.27 2.20 (0.72–5.14)
Diseases of the circulatory
system
11 11.89 0.92 (0.46–1.66) 3 2.26 1.33 (0.27–3.88) 8 9.63 0.83 (0.36–1.64)
Diseases of the respiratory
system
17 4.59 3.70 (2.16–5.93) 0.001 14 3.00 4.67 (2.55–7.83) 0.001 3 1.60 1.88 (0.39–5.48)
Diseases of the digestive
system
3 2.09 1.44 (0.30–4.19) 2 1.09 1.83 (0.22–6.63) 1 0.99 1.01 (0.03–5.63)
Diseases of the genitourinary
system
1 1.10 0.91 (0.02–5.07) 1 0.62 1.60 (0.04–8.99) 0 0.47 0.00 (0.00–7.85)
Congenital malformations and
chromosomal abnormalities
22 23.08 0.95 (0.60–1.44) 20 21.76 0.92 (0.56–1.42) 2 1.32 1.52 (0.18–5.47)
Other diseases 27 29.74 0.91 (0.60–1.32) 25 28.44 0.88 (0.57–1.30) 2 1.29 1.55 (0.19–5.60)
Unknown 5 2.57 1.94 (0.63–4.54) 4 1.81 2.21 (0.60–5.66) 1 0.76 1.31 (0.03–7.33)
Alcohol–related diseases 3 3.77 0.80 (0.16–2.33) 0 0.15 0.00 (0.00–24.59) 3 3.62 0.83 (0.17–2.42)
Accidents and violence 58 74.14 0.78 (0.59–1.01) 23 34.07 0.68 (0.43–1.01) 35 40.08 0.87 (0.61–1.21)
Accidents 28 44.04 0.64 (0.42–0.92) 0.01 16 25.84 0.62 (0.35–1.01) 12 18.20 0.66 (0.34–1.15)
Suicides 23 22.51 0.98 (0.62–1.47) 5 5.48 0.91 (0.30–2.13) 18 18.03 1.00 (0.59–1.58)
Homicides 4 4.08 0.98 (0.27–2.51) 2 1.74 1.15 (0.14–4.15) 2 2.34 0.82 (0.10–3.09)
Unknown 3 2.31 1.30 (0.27–3.80) 0 0.90 0.00 (0.00–4.10) 3 1.41 2.12 (0.44–6.22)
Other 0 0.20 0.00 (0.00–18.44) 0 0.11 0.00 (0.00–33.54) 0 0.09 0.00 (0.00–40.99)
CI  confidence interval; SMR  standardized mortality ratio with 95% confidence limits.
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Deaths After Pediatric Cardiac Surgery September 25, 2007:1263–71The most common cause of death among patients was the
eart defect. Only patients with ASD and PDA died more
ften owing to non–CHD-related causes. The mortality of
SD patients resembled that of the general population. Our
tudy confirmed the previously reported higher-than-
xpected mortality of the PDA patients (6,7), which re-
ulted from non-cardiac diseases. Thus, the ASD and PDA
atients who underwent surgery could be considered cured.
ode of CHD-related deaths. The most common mode
f CHD-related death was heart failure. Most of the
atients with lethal heart failure had diagnosed pulmonary
ypertension. Part of the late mortality could perhaps have
een avoided with more careful follow-up and subsequent
nterventions, thus preventing the further rise of pulmonary
esistance.
In our subjects, the number of late deaths due to surgery
as high and resulted mainly from the patient’s subsequent
orrective operation, whereas the follow-up began from the
rst—often palliative—operation (e.g., shunt in TOF).
Sudden death occurred most often in older patients with
orrected heart defects and with known high risk of sudden
eath (18). The overall survival of patients with operated
oA was good: over 90% for 30 years. Yet the risk of
udden death was high. This obligates health professionals
o ensure the careful follow-up and treatment of patients;
he survivors of CoA repair are fixed, not cured (19).
Surprisingly, we discovered that male patients with cor-
ected TOF and TGA died suddenly more often than
emale patients. The number of sudden deaths was small,
nd the significance of the difference was weak, but it
xisted nevertheless. When the 2 diagnostic groups were
ombined, the significance of the difference strengthened.
ender might be one of the fatal factors that contribute to
udden death in CHDs. Yet the causes of the difference
eed to be examined. This same kind of gender differences
n sudden death has been published among adults with
ifferent heart diseases. For instance, male patients with
oronary heart disease and male athletes die suddenly more
ften than female patients (9,20). In addition, the types of
rrhythmias differ between men and women (8).
In the cardiovascular mode of CHD-related death, some
ata aroused our attention. The overall incidence of lethal
ndocarditis was only 0.07%. None of the deaths due to
ndocarditis occurred in patients with a valve prosthesis,
lthough they are believed to carry a high risk for it (21).
et, the other 2 patient groups at high risk for infective
ndocarditis were among our subjects: patients with aortic
alve disease and cyanotic heart defect (21).
The number of deaths due to bleeding after anti-
oagulation therapy was very low in our study, confirming
he previously reported low incidence of fatal bleeding
mong young patients (22). When only mortality for endo-
arditis and bleeding is concerned, the artificial heart valve
eems a safe alternative for young patients.
Previous studies have reported that patients with CoA are
t high risk for death due to coronary disease and cerebro- pascular accidents (1). Our findings, however, differed.
mong the patients who underwent a successful operation
or CoA (n  887), only 1 death resulted from coronary
eart disease. Even this death was classified as non–CHD-
elated, because of the patient’s severe diabetes and kidney
ransplant, which have been reported to increase one’s risk
or all cardiovascular diseases (23). Moreover, only 1 of the
atients died owing to a cerebrovascular accident; this death
esulted from the combination of warfarin and alcohol. In
arlier reports, a younger age at CoA repair has protected
atients against lethal complications (1). Our study con-
rmed this, because all of our patients underwent surgery
efore their 15th birthday.
nrelated deaths. The greatest difference between the
atients and the general population appeared in the deaths
aused by respiratory diseases. Most patients within this
roup died owing to pneumonia. High mortality due to
neumonia has often been connected to mental retardation
24) and seriously ill infants, as was the case in our study.
Neurological diseases caused a relatively high number of
eaths. High mortality due to neurological causes partly
esulted from other malformations and genetic syndromes
ith neurological disorders, which are quite common
mong patients with CHD. Some of the patients, however,
uffered from brain damage caused by the heart defect itself
r by cardiac surgery. Especially in the earlier days of cardiac
urgery, cardiopulmonary bypass and related techniques,
lthough enabling the repair of the heart itself, were not so
entle as to avoid potential brain damage entirely.
The number of accidental deaths was low. This might
ave resulted from the influence of parental over-protection,
sually reported to cause only negative effects (25). One
ight also interpret this phenomenon as a reflection of the
hysical inability of the patients to engage in risky hobbies
r hard physical work that could lead to accidental death.
lternatively, patients with a surgically corrected heart
efect might appreciate life enough to avoid extreme hob-
ies and careless driving habits.
The number of suicides was equal to the number ex-
ected. This observation was in line with a previous study in
hich young adults with congenital heart disease assessed
heir emotional state as similar to that of the control
opulation (26). In some studies, a severe physical illness
as increased suicidal behavior (27,28), but in our study
one of the patients with severe heart defect committed
uicide. The 2 suicides connected to heart defects should
arrant an offer of psychological assistance for patients with
ifficult health problems.
onclusions
ncreased risk of CHD-related death followed patients
hroughout their lives. The high number of deaths due to
espiratory and neurological causes reflects increased comor-
idity. The comorbidity will be studied further among these
atients, because the mortality gave just a rough image of it.
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atients with CHD than among the general population.
he progress of treatment will likely lower the number of
atal complications among patients in the future.
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